Atlas Trials

A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients

Clinical trial NCT06703268 · COMPLETED

Trial details

NCT number
NCT06703268
Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2024-01-15
Primary completion
2024-10-05
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.